Therapeutic development for brain disorders is the longest, costliest, and riskiest of all diseases, with only 6% of candidate therapies obtaining FDA approval. The high failure rate is largely due to the inability to understand the efficacy of the therapies. Their brain mapping technology is changing that. They've placed 1,000+ brain mapping systems in over 400 neuroscience laboratories which has resulted in breakthroughs in the research of the brain circuits of memory, cognition, motor control, and sensory processes.